AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.35
Delayed Data
As of Apr 24
 +0.05 / +2.17%
Today’s Change
1.55
Today|||52-Week Range
5.75
+16.05%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Perceptive Advisors Llc
Sale6/19/2017875,000$2.40$2.1M-6.00%
Edwards Mark G
Director
Buy11/14/201730,000$1.90$57.0K+27.03%
Hamel Lawrence G
Chief Development Officer
Sale10/02/201710,161$5.29$53.8K-57.27%
Dasu Badri N
Chief Engineering Officer
Buy10/19/201737,500$1.20$45.0K+34.29%
Angotti Vincent J
Chief Executive Officer
Buy8/24/201715,000$3.00$45.0K-21.01%
Palmer Pamela Pierce
Chief Medical Officer
Buy8/22/201710,000$2.95$29.5K-20.34%
Asadorian Raffi
Chief Financial Officer
Buy9/11/20177,000$3.24$22.7K-26.56%
Edwards Mark G
Director
Buy8/24/20174,800$3.02$14.5K-21.01%
Asadorian Raffi
Chief Financial Officer
Buy11/13/20175,000$1.94$9.7K+23.68%
Edwards Mark G
Director
Buy8/22/2017200$2.90$580.00-20.34%
Page of 2